Tag: billion-sale

  • Allergan profit beats estimates, share buybacks planned

    The Dublin drugmaker on Tuesday said the planned $40 billion sale of its generics business to Teva Pharmaceutical Industries will close next month and that it will use $8 billion of the money to pay down company debt. Since the U.S. government torpedoed the merger, a deal that would have relocated Pfizer's legal domicile to…